Abstract
Background: In the past few decades, increasing evidence in the literature has appeared describing the role of the antioxidant defense system and redox signaling in the multifactorial pathophysiology of psychosis. It is of interest to clinicians and researchers alike that abnormalities of the antioxidant defense system are associated with alterations of cellular membranes, immune functions and neurotransmission, all of which have some clinical implications.
Methods: This narrative review summarizes the evidence regarding oxidative stress in the early stages of psychosis. We included 136 peer-reviewed articles published from 2007 to 2020 on PubMed EMBASE, The Cochrane Library and Google Scholar.
Results: Patients affected by psychotic disorders show a decreased level of non-enzymatic antioxidants, an increased level of lipid peroxides, nitric oxides, and a homeostatic imbalance of purine catabolism. In particular, a significantly reduced antioxidant defense has been described in the early onset first episode of psychosis, including reduced levels of glutathione. Also, it has been shown that a decreased basal low-antioxidant capacity correlates with cognitive deficits and negative symptoms, mostly related to glutamate-receptor hypofunction. In addition, atypical antipsychotic drugs seem to show significant antioxidant activity. These factors are critical in order to treat cases of first-onset psychosis effectively.
Conclusion: This systematic review indicates the importance that must be given to anti-oxidant defense systems.
Keywords: Glutathione, Superoxide Dismutase, Catalase, Thioredoxin, N-acetylcysteine, Oxidative Stress, Schizophrenia, First Episode of Psychosis (FEP).
Current Topics in Medicinal Chemistry
Title:Oxidative Stress in the Early Stage of Psychosis
Volume: 21 Issue: 16
Author(s): Antonio Ventriglio*, Antonello Bellomo, Favale Donato, Bonfitto Iris, Vitrani Giovanna, Di Sabatino Dario, Cuozzo Edwige, Di Gioia Ilaria, Mauro Pettorruso, Giampaolo Perna, Alessandro Valchera and Domenico De Berardis
Affiliation:
- Department of Clinical and Experimental Medicine, University of Foggia, Foggia,Italy
Keywords: Glutathione, Superoxide Dismutase, Catalase, Thioredoxin, N-acetylcysteine, Oxidative Stress, Schizophrenia, First Episode of Psychosis (FEP).
Abstract:
Background: In the past few decades, increasing evidence in the literature has appeared describing the role of the antioxidant defense system and redox signaling in the multifactorial pathophysiology of psychosis. It is of interest to clinicians and researchers alike that abnormalities of the antioxidant defense system are associated with alterations of cellular membranes, immune functions and neurotransmission, all of which have some clinical implications.
Methods: This narrative review summarizes the evidence regarding oxidative stress in the early stages of psychosis. We included 136 peer-reviewed articles published from 2007 to 2020 on PubMed EMBASE, The Cochrane Library and Google Scholar.
Results: Patients affected by psychotic disorders show a decreased level of non-enzymatic antioxidants, an increased level of lipid peroxides, nitric oxides, and a homeostatic imbalance of purine catabolism. In particular, a significantly reduced antioxidant defense has been described in the early onset first episode of psychosis, including reduced levels of glutathione. Also, it has been shown that a decreased basal low-antioxidant capacity correlates with cognitive deficits and negative symptoms, mostly related to glutamate-receptor hypofunction. In addition, atypical antipsychotic drugs seem to show significant antioxidant activity. These factors are critical in order to treat cases of first-onset psychosis effectively.
Conclusion: This systematic review indicates the importance that must be given to anti-oxidant defense systems.
Export Options
About this article
Cite this article as:
Ventriglio Antonio*, Bellomo Antonello, Donato Favale , Iris Bonfitto , Giovanna Vitrani , Dario Di Sabatino , Edwige Cuozzo , Di Gioia Ilaria , Pettorruso Mauro , Perna Giampaolo , Valchera Alessandro and De Berardis Domenico, Oxidative Stress in the Early Stage of Psychosis, Current Topics in Medicinal Chemistry 2021; 21 (16) . https://dx.doi.org/10.2174/1568026621666210701105839
DOI https://dx.doi.org/10.2174/1568026621666210701105839 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Adaptogens—History and Future Perspectives
Adaptogens are pharmacologically active compounds or plant extracts that are associated with the ability to enhance the body’s stability against stress. The intake of adaptogens is associated not only with a better ability to adapt to stress and maintain or normalise metabolic functions but also with better mental and physical ...read more
AlphaFold in Medicinal Chemistry: Opportunities and Challenges
AlphaFold, a groundbreaking AI tool for protein structure prediction, is revolutionizing drug discovery. Its near-atomic accuracy unlocks new avenues for designing targeted drugs and performing efficient virtual screening. However, AlphaFold's static predictions lack the dynamic nature of proteins, crucial for understanding drug action. This is especially true for multi-domain proteins, ...read more
Artificial intelligence for Natural Products Discovery and Development
Our approach involves using computational methods to predict the potential therapeutic benefits of natural products by considering factors such as drug structure, targets, and interactions. We also employ multitarget analysis to understand the role of drug targets in disease pathways. We advocate for the use of artificial intelligence in predicting ...read more
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting NO/cGMP Signaling in the CNS for Neurodegeneration and Alzheimer’s Disease
Current Medicinal Chemistry Melatonin and Respiratory Diseases: A Review
Current Topics in Medicinal Chemistry Resveratrol and Lifespan in Model Organisms
Current Medicinal Chemistry Prevalence of Obesity, Hypertension, Diabetes, and Metabolic Syndrome and Its Cardiovascular Complications
Current Hypertension Reviews “PARG Inhibitors’ Success: A Long Way to Go!”
Current Enzyme Inhibition Intravitreal Bevacizumab (Avastin®) for Diabetic Retinopathy at 24-months: The 2008 Juan Verdaguer-Planas Lecture
Current Diabetes Reviews Pharmacologic Targeting of Endothelial Progenitor Cells
Cardiovascular & Hematological Disorders-Drug Targets The Action of Polyphenols in Diabetes Mellitus and Alzheimer's Disease: A Common Agent for Overlapping Pathologies
Current Neuropharmacology Hydrogen Sulfide: Physiological Roles and Therapeutic Implications against COVID-19
Current Medicinal Chemistry Subject Index To Volume 2
Current Cardiology Reviews Cardiac Gene Therapy: Therapeutic Potential and Current Progress
Current Gene Therapy Gesture Interaction for Coronary Heart Diseases Based on Wavelet Transform and Semi-Continuous Hidden Markov Model in Augmented Reality
Recent Advances in Electrical & Electronic Engineering Chemistry and Biological Activities of Buxus Alkaloids
Current Bioactive Compounds Natural Products as a Source of Antiarrhythmic Drugs
Mini-Reviews in Medicinal Chemistry Clinical and Environmental Correlates of Serum BDNF: A Descriptive Study with Plausible Implications for AD Research
Current Alzheimer Research Targeting the MCP-1/CCR2 System in Diabetic Kidney Disease
Current Vascular Pharmacology Apoptosis: Potential Therapeutic Targets for New Drug Discovery
Current Medicinal Chemistry Non-ACE Pathway-induced Angiotensin II Production
Current Pharmaceutical Design Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications
Current Vascular Pharmacology Subject Index to Volume 3
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents